SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001104659-23-068032
Filing Date
2023-06-05
Accepted
2023-06-05 16:06:22
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFR14A tm2317610-1_def14a.htm DEFR14A 974115
2 GRAPHIC lg_avadel-4clr.jpg GRAPHIC 31027
3 GRAPHIC lc_ttlshrholret-4clr.jpg GRAPHIC 172763
4 GRAPHIC lc_gaapnetinc-4clr.jpg GRAPHIC 143701
5 GRAPHIC px_avadelproxy1pg1-4clr.jpg GRAPHIC 961525
6 GRAPHIC px_avadelproxy1pg2-4c.jpg GRAPHIC 623522
  Complete submission text file 0001104659-23-068032.txt   3375009
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-37977 | Film No.: 23992484
SIC: 2834 Pharmaceutical Preparations